Merck

4. Merck

Total Ad Spend: $285.5 million
Television: $133.7 million
Magazine: $87.8 million
Other: $64 million

After resolving the manufacturing and supply problems that constricted supplies of Zostavax for several years, Merck ($MRK) decided on a disease-awareness campaign to herald its revival in the market. The campaign must have worked, because Zostavax was one of the best-selling vaccines last year.


In the spotlight

Shingles awareness, $46.7 million
Nasonex, $46.3 million
Zostavax, $46 million


 

Merck
Read more on

Suggested Articles

Novavax sign
Manufacturing

Novavax scores $60M Department of Defense deal for COVID-19 shot

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

by Eric Sagonowsky
White House
Vaccines

Experts question why some vaccines were left out of 'Warp Speed'

Since the Warp Speed selections went public, experts have been wondering why some drugmakers were left off.

by Eric Sagonowsky
Syringe injection vaccine needle
Manufacturing

Inovio sues manufacturing partner over COVID-19 shot scale-up

Vaccine maker Inovio has accused a longtime manufacturing partner of hampering its efforts to produce 1 million doses of a potential COVID-19 vaccine.

by Kyle Blankenship